Outpatient Management of Fever and Neutropenia in Low-risk Children with Solid Tumors: A Quality Improvement Initiative

被引:1
|
作者
Bourgeois, Wallace [1 ,2 ]
Paolino, Jonathan [1 ,2 ]
Garland, Riley [1 ,2 ]
Campbell, Kevin [1 ,2 ]
Alvarez-Calderon, Francesca [1 ,2 ]
Frazier, A. Lindsay [1 ,2 ]
O'Neill, Allison F. [1 ,2 ]
Ilowite, Maya [1 ,2 ]
Wong, Chris I. [1 ,2 ,3 ,4 ]
机构
[1] Dana Farber Canc Inst, Boston Childrens Canc & Blood Disorders Ctr, Boston, MA USA
[2] Harvard Med Sch, Dept Pediat Oncol, Boston, MA USA
[3] Univ Hosp Rainbow Babies & Childrens Hosp, Div Pediat Hematol & Oncol, 11100 Euclid Ave, Cleveland, OH 44106 USA
[4] Case Western Reserve Univ, Univ Hosp Seidman Canc Ctr, Div Hematol Oncol, Sch Med, Cleveland, OH USA
关键词
CANCER;
D O I
10.1097/pq9.0000000000000771
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Background:Management of febrile neutropenia in pediatric oncology usually requires inpatient parenteral antibiotics after initial evaluation, but some patients at lower risk of sepsis could be safely managed outpatient. We describe a quality improvement project to increase outpatient management of fever and neutropenia.Methods:We designed a standardized algorithm for children with a solid tumor diagnosis and low risk for bacteremia. The aim was to achieve outpatient management for at least 80% of eligible patients within 20 months of project initiation. We used plan-do-study-act cycles to improve algorithm compliance, including optimizing medical record decision support, developing targeted educational materials and outreach, and restructuring outpatient processes to allow for close follow-up. We surveyed patients (age >= 12 y) and parents/caregivers to assess the impact of outpatient management.Results:The initiative led to 71% (n = 34) of eligible patients being managed as outpatients. Six percent (n = 2) of patients developed bacteremia, resulting in hospital admission. Fifteen of 26 parents/caregivers and five of 11 patients approached completed the survey. For the preferred setting of febrile neutropenia management, 83% of patients preferred to be home versus 40% of parents/caregivers. No patient expressed any of the three highest ratings in the question exploring fear regarding outpatient febrile neutropenia management versus 67% of parents/caregivers.Conclusions:Some children with a solid tumor diagnosis at low risk for bacteremia are safely managed for febrile neutropenia as outpatients. Targeted efforts to engage parents/caregivers early in this practice change are necessary for success.
引用
收藏
页数:7
相关论文
共 17 条
  • [1] Outpatient and oral antibiotic management of low-risk febrile neutropenia are effective in children—a systematic review of prospective trials
    A. Manji
    J. Beyene
    L. L. Dupuis
    R. Phillips
    T. Lehrnbecher
    L. Sung
    Supportive Care in Cancer, 2012, 20 : 1135 - 1145
  • [2] Cost-effectiveness and Improved Parent and Provider Satisfaction With Outpatient Management of Pediatric Oncology Patients, With Low-risk Fever and Neutropenia
    Bavle, Abhishek
    Grimes, Amanda
    Zhao, Sibo
    Zinn, Daniel
    Jackson, Andrea
    Patel, Binita
    Porea, Timothy
    Dutta, Ankhi
    Russell, Heidi
    Heczey, Andras
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2018, 40 (07) : E415 - E420
  • [3] Outpatient and oral antibiotic management of low-risk febrile neutropenia are effective in children-a systematic review of prospective trials
    Manji, A.
    Beyene, J.
    Dupuis, L. L.
    Phillips, R.
    Lehrnbecher, T.
    Sung, L.
    SUPPORTIVE CARE IN CANCER, 2012, 20 (06) : 1135 - 1145
  • [4] Outcomes of a clinical pathway for primary outpatient management of pediatric patients with low-risk febrile neutropenia
    Paolino, Jonathan
    Mariani, Juliana
    Lucas, Alexandra
    Rupon, Jeremy
    Weinstein, Howard
    Abrams, Annah
    Friedmann, Alison
    PEDIATRIC BLOOD & CANCER, 2019, 66 (07)
  • [5] Outpatient treatment of fever and neutropenia for low risk pediatric cancer patients
    Mullen, CA
    Petropoulos, D
    Roberts, WM
    Rytting, M
    Zipf, T
    Chan, KW
    Culbert, SJ
    Danielson, M
    Jeha, SS
    Kuttesch, JF
    Rolston, KV
    CANCER, 1999, 86 (01) : 126 - 134
  • [6] Shorter Duration of Antibiotics in Low-Risk Febrile Neutropenia in Children with Malignancy
    Meena, Jagdish Prasad
    Gupta, Aditya Kumar
    INDIAN JOURNAL OF PEDIATRICS, 2021, 88 (03) : 217 - 218
  • [7] Early discharge of pediatric patients with cancer, fever, and neutropenia with low-risk of systemic infection
    Gil-Veloz, Mariana
    Pacheco-Rosas, Daniel O.
    Solorzano-Santos, Fortino
    Villasis-Keeyer, Miguel A.
    Betanzos-Cabrera, Yadira
    Miranda-Novales, Guadalupe
    BOLETIN MEDICO DEL HOSPITAL INFANTIL DE MEXICO, 2018, 75 (06): : 352 - 357
  • [8] Outpatient treatment of low-risk neutropenic fever in cancer patients using oral moxifloxacin
    Chamilos, G
    Bamias, A
    Efstathiou, E
    Zorzou, PM
    Kastritis, E
    Kostis, E
    Papadimitriou, C
    Dimopoulos, MA
    CANCER, 2005, 103 (12) : 2629 - 2635
  • [9] Protocol for a systematic review of reductions in therapy for children with low-risk febrile neutropenia
    Morgan J.E.
    Stewart L.
    Phillips R.S.
    Systematic Reviews, 3 (1)
  • [10] The prognostic performance of adding patient-reported outcomes to the MASCC risk index to identify low-risk febrile neutropenia patients with solid tumors and lymphomas
    Xiao Jun Wang
    Denise Yun Ting Goh
    Sreemanee Raaj Dorajoo
    Alexandre Chan
    Supportive Care in Cancer, 2017, 25 : 2815 - 2822